Cargando…
Personalized management of prostate cancer: from molecular and imaging markers to radiogenomics
PURPOSE: Prostate cancer (PCa) is the second most common cancer in men. The urge to guide treatment tactics based on personal clinical risk factors has evolved in the era of human genome sequencing. To date, personalized approaches to managing PCa patients have not yet been developed. Radiogenomics...
Autores principales: | Mytsyk, Yulian, Borzhiyevs’kyy, Andriy, Kobilnyk, Yuriy, Shulyak, A.V., Dutka, Ihor, Borzhiyevs’kyy, Oleksandr, Górecki, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814894/ https://www.ncbi.nlm.nih.gov/pubmed/35140829 http://dx.doi.org/10.5114/pjr.2022.113204 |
Ejemplares similares
-
Local recurrence of renal cell carcinoma after partial nephrectomy: applicability of the apparent diffusion coefficient of MRI as an imaging marker – a multicentre study
por: Mytsyk, Yulian, et al.
Publicado: (2022) -
Value of the Diffusion-Weighted MRI in the Differential Diagnostics of Malignant and Benign Kidney Neoplasms – Our Clinical Experience
por: Mytsyk, Yulian, et al.
Publicado: (2014) -
Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021) -
Physical and Numerical Simulations for Predicting Distribution of Microstructural Features during Thermomechanical Processing of Steels
por: Poloczek, Łukasz, et al.
Publicado: (2022) -
Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma
por: Mytsyk, Yulian, et al.
Publicado: (2018)